Polymeric Model System for Protein-Bilirubin Interaction by Eijk, J.M. van der et al.
PDF hosted at the Radboud Repository of the Radboud University
Nijmegen
 
 
 
 
This full text is a publisher's version.
 
 
For additional information about this publication click this link.
http://hdl.handle.net/2066/16469
 
 
 
Please be advised that this information was generated on 2014-11-13 and may be subject to
change.
COMMUNICATIONS TO THE EDITOR
Polymeric Model System for Protein-Bilirubin Interaction
Bilirubin is the end product of heme catabolism in man and most animals and is ultimately 
excreted into the bile.1 The compound has a low solubility in aqueous media. Almost all 
of the bilirubin transported in the blood is tightly bound to serum albumin .2 It is assumed  
that charged residues of histidine, arginine, and tyrosine are involved in the binding ,3 while 
one lysine group is close to the binding site .'1 The nature of the binding of bilirubin to serum 
albumin is still unknown, although recent data suggest that salt linkages and hydrogen bonds 
rather than hydrophobic interactions are the main factors in the binding .5
Recently, we prepared6 two polymers (Scheme I) with an imidazole ring in each repeating
H
CH - C ~ N = C ^
2  I n
X
l a ,  X= COOH 
n l b ,  X=H
unit, viz., poly(carbylhistidine), la, and poly(carbylhistamine), lb. Their official names are 
poly[3-(4-imidazolyl)-2-isocyanopropanoic acid] and poly[2-(4-imidazolyl)-l-isocyanoethane|, 
respectively. Trivial names are used for the sake of simplicity. These polymers might serve 
as models for the interaction of bilirubin with charged and uncharged imidazole sites in serum 
albumin. The two polymers have appreciably different p/Ca (Im) values: pA'a( la) = 9.4 and 
pR'n( lb )  = 5.2.6 Therefore, at pH of blood plasma, the imidazole groups in poly(carbylhis- 
tidine) are nearly completely protonated, whereas in poly(carbylhistamine) these groups are 
nearly completely unprotonated. We wish to report here that at pH 7.3, bilirubin interacts 
only with the polymer having unprotonated imidazole groups, suggesting that salt linkages 
are probably not of major importance in the binding of bilirubin to histidyl residues of serum 
albumin.
Degassed solutions of bilirubin (Merck p.a.) in 0.01 mol/1. aqueous NaOH were added at 
0°C to solutions of polymer la  or lb  in aqueous phosphate buffer of pH 7.3. In the solution  
containing polymer 1 b, a precipitate was formed immediately. After vigorous shaking, a fine 
suspension was obtained, which had a \ max at 445 nm in the visible spectrum. A reference 
solution containing bilirubin and buffer only showed a Amax at 438 nm (f = 41,000). In the 
solution containing polymer la ,  neither a precipitate nor a Amax shift was observed. The  
immediate formation of a precipitate with lb  indicates an interaction between bilirubin and 
this polymer. The shift in the absorption maximum from 438 to 445 nm supports such an 
interaction. There is a remarkable increase in the stabilitv of the bilirubin when attached 
to the polymer: the precipitate did not change on prolonged standing at room temperature, 
whereas free bilirubin does. However, on treatment of the precipitate with acid, the bilirubin 
was set free quantitatively.
The composition of the polymer-bilirubin complex was determined as follows. Samples  
of bilirubin in 10% ethanol/0.005 mol/1. NaOH were taken from a cooled (0°C) and degassed  
stock solution (concentration of bilirubin, 6.0 X 10“ 4 mol/1.) and added to 25 ml of a cooled 
(0°C) and degassed aqueous phosphate buffer o f  pH 7.3 and ionic strength of 0.14 mol/1. 
containing polymer lb. The volume was adjusted to 35 ml with 10% ethanol/0.005 mol/1. 
NaOH. The final concentration of 1 b was 2.0 X 10~A mol/1. The concentration range of  bi­
lirubin was (0.8-17) X 10-5 mol/1. Precipitates were formed at once. After shaking the re­
action mixtures for 2 min, the precipitates were collected by centrifugation, dried over P2O5, 
and weighed. The results are given in Table I. The uv-visible spectrum of the supernatant  
showed that the remaining solution contained polymer and a negligible amount of bilirubin. 
The total weight of precipitate is plotted against the initial amount of bilirubin added in Fig.
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Composition of Poly(Carbylhistamine)-Bilirubin Complex
Initial
Bilirubin
(mg)
Total
Precipitate
(mg)
Bilirubin in 
Precipitate0 
(mmol X 10- 4 )
Polymerb in 
Precipitate0 
(mmol X 10- 2 )
Molar 
Ratio of  
Bilirubin 
to Polymer
0.18 1.4 1.99 1.03 0.019
0.35 2.9 4.13 1.43 0.029
0.70 3.6 9.58 2.09 0.046
1.06 4.7 15.8 2.61 0.061
1.41 5.9 24.0 2.96 0.081
1.76 5.5 28.1 3.16 0.089
2.11 6.8 31.7 3.31 0.096
2.81 8.2 46.5 3.97 0.12
3.52 9.6 59.3 4.55 0.13
a As measured by uv spectroscopy. See text for experimental details. 
b Expressed per polymer unit.
1. Apart from the initial stage, probably related to a precipitate of different composition,  
the plot is linear. The linearity suggests that the complex formed has a fixed ratio of bilirubin 
to polymer. This ratio can be calculated from the slope s of the plot in Fig. 1. This slope is 
related to the number of bilirubin molecules bound per polymer repeating unit i> as fol­
lows:
(s -  l )r  = M r polymer repeating unit/M r bilirubin
Taking 584 and 121 as the molecular weights of bilirubin and polymer repeating unit, re­
spectively, v was calculated to be 0.20 ±  0.02. It is worth noting here that this value of v 
strongly deviates from the bilirubin:polymer ratio, which can be expected when bilirubin is 
distributed statistically over the polymer. This ratio ranges from 0.004 for the lowest to 0.085 
for the highest bilirubin addition.
P
Fig. 1. Total weight of precipitate, P (in mg), as a function of initial amount of bilirubin, 
bo, added to the polymer solution.
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Fig. 2. Structure of  bilirubin.
The composition of the complex was also determined by uv spectroscopy. The precipitates 
were dissolved in 10 ml 0.1 mol/l. aqueous HC1, and these solutions were extracted immediately 
with chloroform. The amounts of bilirubin and polymer were calculated from the absorbances 
of the chloroform and water solutions, respectively. We determined the molecular extinction 
coefficients of bilirubin in chloroform at 450 nm and of 1 b in 0.1 mol/l. HC1 at 300 nm to be 
51,000 and 1440, respectively. The molar ratios of bilirubin to polymer are given in Table
I. A plot of the molar amount of bilirubin versus the molar amount of polymer, expressed 
per polymer unit, in the precipitates gave a curve which was very similar to the one in Fig.
1. The number of bilirubin molecules bound per polymer repeating unit was calculated from 
the slope of its linear part to be v = 0.21 ±  0 .01. This is in agreement with the value of r =
0.20 obtained from Fig. 1.
Polymers like 1 b  have a rigid-rod helical structure with approximately four repeating units, 
R — N = C ,  per helical turn .7 In polymer l b , R = ImCH-jCHj— . Thus the binding of one 
molecule of bilirubin to five polymer units is equivalent to slightly less than one molecule of 
bilirubin per helical turn. Probably each of both ends of a bilirubin molecule is attached to 
an imidazole group. 'These ends could be coordinated to imidazole rings of either the same  
polymer molecule or different polymer molecules. In the former case, four bilirubin molecules 
will be bound to the polymer along its longitudinal axis over four to five helical turns in a very 
close packing. In the latter case the bilirubin acts as a crosslinking agent. We prefer the latter 
case over the former one because of the nonstatistical distribution of bilirubin over the 
polymer. Such a distribution can be visualized more easily for an orderly network than for 
a single chain complex.
At pH 7.3 bilirubin is a dianion .5 From the fact that this dianion binds to the neutral 
compound lb  and not to protonated la ,  one can conclude that the binding of bilirubin to 
polvmer-bound imidazole does not involve salt linkages. (Catalytic experiments with polymer 
la  show that the repulsive effect by the polymer COO“ groups on charged substrates is small.8) 
Instead we prefer hydrogen bonds because such bonds are quite possible. It is well known 
that a neutral imidazole can act both as a hydrogen acceptor and a hydrogen donor. Bilirubin 
itself is a hydrogen bond donor through the weakly acidic protons in its lactam rings and an 
acceptor through the slightly basic pyrrolic nitrogens, as well as its COO-  functions (Fig. 
2).9
Our findings with the polymeric model systems la  and lb  have interesting implications 
for the type of binding of bilirubin to serum albumin. At the pH of blood plasma bilirubin 
might interact with the albumin mainly through the uncharged imidazole group of histidine 
in the protein. The function of imidazole in the binding process will be that of a proton donor 
and proton acceptor. If present, salt linkages will only occur to arginine and lysine resi­
dues.
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